Drug delivery device

AU202612665SUndetermined Publication Date: 2026-07-16REGENERON PHARMACEUTICALS INC
0 Cites 0 Cited by

Patent Information

Application Number
AU2026012665D
Authority / Receiving Office
AU · AU
Patent Type
Designs
Current Assignee / Owner
Priority Date
2024-12-23
Filing Date
2026-04-02
Publication Date
2026-07-16
Estimated Expiration
2036-04-02

Smart Images

  • Figure 202612665_1
    Figure 202612665_1
  • Figure 202612665_2
    Figure 202612665_2
  • Figure 202612665_3
    Figure 202612665_3
Patent Text Reader

Abstract

Newness and distinctiveness reside in the visual features of the design as shown in the representations. Features shown in even broken lines in the representations form no part of the design for which protection is sought. Except for the oblique shading lines representing a transparent or translucent surface of the design, shading lines are present to show contour and not surface ornamentation.
Need to check novelty before this filing date? Find Prior Art